Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 260 participants.

Also called NCT06683040

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 260 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06683040
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06683040. Randomized; quadruple masking; primary purpose treatment. Start 2024-06-01 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension
Condition
Pulmonary Arterial Hypertension
Intervention (Drug)
Oxacom
Intervention (Drug)
Placebo
Lead sponsor
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation (class: other government)

Record details

Record id
cardio:ct-nct06683040
Content hash
ba974e58204d2a45e7cc80662724c17693fbc158fb16224f987883274e26ae60